General Editor

Michael W. Kattan is Chairman of the Department of Quantitative Health Sciences at Cleveland Clinic. He is also Professor of Medicine, Epidemiology, and Biostatistics at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Prior to joining Cleveland Clinic, he was Associate Attending Outcomes Research Scientist at Memorial Sloan-Kettering Cancer Center and Associate Professor of Biostatistics in Urology at Cornell University in New York City. He began his academic career as an assistant professor of urology and medical informatics at Baylor College of Medicine in Houston, Texas, where he also obtained his post-doctorate in medical informatics.

His primary research interest lies in prescriptive medical decision making—how physicians and patients should make decisions. Specifically, he is most interested in medical prediction: how, why, and when. He has received multiple patents for his work in this area and coauthored about 300 articles in peer-reviewed journals. In 2008, he received the Eugene Saenger Distinguished Service Award from the Society for Medical Decision Making. He serves or has served on the editorial boards for several journals, including Cancer Investigation, Nature Clinical Practice Urology, Medical Decision Making, Clinical Genitourinary Cancer, Urologie Oncology, Journal of Urology, and Urologie Oncology: Seminars and Original Investigation. His PhD is in management information systems, with a minor in statistics, from the University of Houston. He also has a master's of business administration, with concentration in computer information systems and quantitative analysis, from the University of Arkansas. His undergraduate degree is in food science, also from the University of Arkansas.

Associate Editor

Mark E. Cowen, MD, is Chief of Clinical Decision Services at the St. Joseph Mercy Health System, Ann Arbor, Michigan. He was founder and president of a private group practice in internal medicine and served as a clinical instructor for the University of Michigan Medical School for a number of years. After receiving a master of science degree in epidemiology from the Harvard School of Public Health, he was Vice President, Performance Improvement, of Allegiance LLC, a physician-hospital organization for managed care. He is currently on the editorial board of the American Journal of Managed Care. His research has been largely driven by questions arising from daily responsibilities with managed care or hospitalized patient populations. A concurrent interest in prostate cancer screening and treatment decisions led to the development of a Markov model and collaborations with Dr. Kattan to study various components of decision making regarding this disease. He has been a member of the prostate cancer outcomes task force of the American Urological Association. He received his undergraduate and medical degrees from the University of Michigan.